Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Imaging systemic inflammatory networks in ischemic heart disease.
J. Am. Coll. Cardiol. 65, 1583-1591 (2015)
While acute myocardial infarction mortality declines, patients continue to face reinfarction and/or heart failure. The immune system, which intimately interacts with healthy and diseased tissues through resident and recruited leukocytes, is a central interface for a global host response to ischemia. Pathways that enhance the systemic leukocyte supply may be potential therapeutic targets. Pre-clinically, imaging helps to identify immunity's decision nodes, which may serve as such targets. In translating the rapidly-expanding pre-clinical data on immune activity, the difficulty of obtaining multiple clinical tissue samples from involved organs is an obstacle that whole-body imaging can help overcome. In patients, molecular and cellular imaging can be integrated with blood-based diagnostics to assess the translatability of discoveries, including the activation of hematopoietic tissues after myocardial infarction, and serve as an endpoint in clinical trials. In this review, we discuss these concepts while focusing on imaging immune activity in organs involved in ischemic heart disease.
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Schlagwörter Atherosclerosis ; Heart Failure ; Hematopoiesis ; Leukocytes ; Myocardial Infarction ; Spleen; Acute Myocardial-infarction; Iron-oxide Nanoparticles; In-vivo; Monocyte Subsets; Atherosclerotic Lesions; Ly-6c(high) Monocytes; Arterial Inflammation; Cardiovascular Events; Progenitor Cells; Dendritic Cells
ISSN (print) / ISBN 0735-1097
Zeitschrift Journal of the American College of Cardiology
Quellenangaben Band: 65, Heft: 15, Seiten: 1583-1591
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed